1. Antimetastatic effect of the pharmacological inhibition of serine/arginine-rich protein kinases (SRPK) in murine melanoma
   Gabriela Alves Moreira et al, 2018, Toxicology and Applied Pharmacology CrossRef
2. Identification of Master Regulators Driving Disease Progression, Relapse, and Drug Resistance in Lung Adenocarcinoma
   Qiong Xu et al, 2022, Frontiers in Bioinformatics CrossRef
3. Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives
   Ilias P. Nikas et al, 2019, Cells CrossRef
4. Therapeutic Targeting of Alternative Splicing: A New Frontier in Cancer Treatment
   Anthony J. Murphy et al, 2022, Frontiers in Oncology CrossRef
5. SRPKs: a promising therapeutic target in cancer
   Muhammad Tufail et al, 2023, Clinical and Experimental Medicine CrossRef
6. Serine-Arginine Protein Kinase 1 (SRPK1): a systematic review of its multimodal role in oncogenesis
   William P. Duggan et al, 2022, Molecular and Cellular Biochemistry CrossRef
7. Serine arginine protein kinase 1 (SRPK1): a moonlighting protein with theranostic ability in cancer prevention
   Mitesh Patel et al, 2019, Molecular Biology Reports CrossRef
8. SR Splicing Factors Promote Cancer via Multiple Regulatory Mechanisms
   Ledong Wan et al, 2022, Genes CrossRef
9. Increased expression of SRPK1 (serine/arginine-rich protein-specific kinase 1) is associated with progression and unfavorable prognosis in cervical squamous cell carcinoma
   Zhanfei Dong et al, 2022, Bioengineered CrossRef